Lawrence; Daniel A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lawrence; Daniel A..The latest application filed is for "plasminogen activator inhibitor-1 (pai-1) inhibitor and method of use".

Company Profile

2.15.19

Lawrence; Daniel A. - Ann Arbor MI
Lawrence; Daniel A. - Derwood MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use Grant 11,426,368 - Lawrence , et al. August 30, 2	2022-08-30
Plasminogen Activator Inhibitor-1 (pai-1) Inhibitor And Method Of Use App 20200147007 - Lawrence; Daniel A. ; et al.	2020-05-14
Protein Kinase C Inhibition To Extend Tissue Plasminogen Activator Treatment For Ischemic Disease App 20190076510 - Lawrence; Daniel A. ; et al.	2019-03-14
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof App 20170291893 - Lawrence; Daniel A. ; et al.	2017-10-12
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof Grant 9,718,760 - Lawrence , et al. August 1, 2	2017-08-01
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 9,527,878 - Lawrence , et al. December 27, 2	2016-12-27
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism App 20160009748 - Lawrence; Daniel A. ; et al.	2016-01-14
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof App 20150315178 - Lawrence; Daniel A. ; et al.	2015-11-05
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 9,120,744 - Lawrence , et al. September 1, 2	2015-09-01
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 9,096,501 - Lawrence , et al. August 4, 2	2015-08-04
Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism App 20140343321 - Lawrence; Daniel A. ; et al.	2014-11-20
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 8,759,327 - Lawrence , et al. June 24, 2	2014-06-24
Plasminogen Activator Inhibitor Amelioration Of Newborn Hypoxic Ischemic Brain Injury App 20100286053 - Kuan; Chia-Yi ; et al.	2010-11-11
Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism App 20100137194 - Lawrence; Daniel A. ; et al.	2010-06-03
Methods for treating conditions associated with the accumulation of excess extracellular matrix Grant 7,713,924 - Noble , et al. May 11, 2	2010-05-11
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism App 20090011055 - Lawrence; Daniel A. ; et al.	2009-01-08
Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof Grant 7,388,074 - Lawrence , et al. June 17, 2	2008-06-17
Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein Grant 7,375,076 - Lawrence , et al. May 20, 2	2008-05-20
Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator App 20070259806 - Hastings; Gregg A. ; et al.	2007-11-08
Mutant proteinase-inhibitors and uses thereof Grant 7,264,953 - Lawrence , et al. September 4, 2	2007-09-04
Brain-associated inhibitor of tissue-type plasminogen activator Grant 7,235,529 - Coleman , et al. June 26, 2	2007-06-26
Brain associated inhibitor of tissue-type plasminogen activator Grant 7,087,574 - Lawrence , et al. August 8, 2	2006-08-08
Mutant proteinase-inhibitors and uses thereof App 20060121591 - Lawrence; Daniel A. ; et al.	2006-06-08
Methods for treating conditions associated with the accumulation of excess extracellular matrix App 20050037007 - Noble, Nancy A. ; et al.	2005-02-17
Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein App 20050019329 - Lawrence, Daniel A. ; et al.	2005-01-27
Brain-associated inhibitor of tissue-type plasminogen activator App 20040203101 - Hastings, Gregg A. ; et al.	2004-10-14
Brain associated inhibitor of tissue - type plasminogen activator App 20040038880 - Lawrence, Daniel A. ; et al.	2004-02-26
Mutant proteinase-inhibitors and uses thereof App 20040014190 - Lawrence, Daniel A. ; et al.	2004-01-22
Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof App 20030216321 - Lawrence, Daniel A. ; et al.	2003-11-20
Brain-associated inhibitor of tissue-type plasminogen activator App 20020165147 - Yepes, Manuel ; et al.	2002-11-07
Brain-associated inhibitor of tissue-type plasminogen activator App 20020143165 - Lawrence, Daniel A. ; et al.	2002-10-03
Peptide mediated enhancement of thrombolysis methods and compositions Grant 5,639,726 - Lawrence , et al. June 17, 1	1997-06-17

Company Registrations

NCAGE Code	4QRT0	LAWRENCE DANIEL A
CAGE Code	4QRT0	LAWRENCE, DANIEL A

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.